Anterior ciliary artery ligation with simultaneous intravitreal bevacizumab: an adjuvant treatment for end-stage neovascular glaucoma.
Ghaffariyeh
Alireza
A
Honarpisheh
Nazafarin
N
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D019842:Ciliary Arteries / Q000601:surgery*; D003131:Combined Modality Therapy; D015355:Glaucoma, Neovascular / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure; D017075:Laser Coagulation; D008026:Ligation; D009801:Oculomotor Muscles / Q000601:surgery; D014821:Vitrectomy; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab